ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Pile Into CoreWeave as EV Names Stay Toxic

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CoreWeave is the week's standout mover among large-cap shorts. Short interest as a percentage of free float hit 24.8%, up from 21.2% seven days ago, a gain of 3.6 percentage points. That is a sharp climb for a $25 billion AI infrastructure play. Bears are circling ahead of a heavy earnings week, with market commentary flagging short sellers targeting AI-linked names as $5 trillion in market cap prepares to report.

EV stocks remain a graveyard. Lucid Group sits at 64.7% SI of free float, with availability near zero at 0.02%, meaning almost no new shares are available to borrow. Hertz holds at 72.3% with a cost to borrow of 190%, one of the most punishing borrow rates in the market. ORTEX alt data shows US plug-in vehicle registrations hit a four-year July low at 21,482. That backdrop keeps short sellers comfortable holding these positions.

Wolfspeed carries 83.8% SI of free float with 9.6 days to cover, a squeeze candidate if any positive catalyst lands.

1-800-Flowers holds at 78.4% SI of free float, barely moving over the past month. The stock is down 25% in three months.

Porsche saw SI jump 3.2 points in the week to 27.3%. European auto names broadly face pressure. Mercedes-Benz and Volkswagen both report this week, with ORTEX alt data showing Dutch car registrations running 6% below the same quarter last year for both groups.

Stocks in this article

How this article was generated

Generated
25 Oct 2026, 16:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.